Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

IGMS | IGM Biosciences Inc

Index	RUT	P/E	-	EPS (ttm)	-5.27	Insider Own	60.71%	Shs Outstand	29.39M	Perf Week	3.04%
Market Cap	393.44M	Forward P/E	-	EPS next Y	-4.50	Insider Trans	0.36%	Shs Float	20.72M	Perf Month	-1.32%
Income	-234.34M	PEG	-	EPS next Q	-1.22	Inst Own	42.12%	Short Float / Ratio	27.24% / 21.21	Perf Quarter	-17.29%
Sales	1.67M	P/S	235.59	EPS this Y	3.62%	Inst Trans	-0.69%	Short Interest	5.64M	Perf Half Y	-51.50%
Book/sh	4.90	P/B	1.52	EPS next Y	12.29%	ROA	-44.10%	Target Price	22.09	Perf Year	-62.25%
Cash/sh	7.35	P/C	1.02	EPS next 5Y	-	ROE	-73.92%	52W Range	6.45 - 28.20	Perf YTD	-56.14%
Dividend	-	P/FCF	-	EPS past 5Y	-71.19%	ROI	-79.94%	52W High	-73.55%	Beta	-0.24
Dividend %	-	Quick Ratio	9.07	Sales past 5Y	0.00%	Gross Margin	-638.14%	52W Low	15.66%	ATR	0.53
Employees	258	Current Ratio	9.07	Sales Q/Q	22.40%	Oper. Margin	-14845.07%	RSI (14)	48.36	Volatility	8.77% 7.16%
Optionable	Yes	Debt/Eq	0.16	EPS Q/Q	-7.01%	Profit Margin	-14007.47%	Rel Volume	0.47	Prev Close	7.28
Shortable	Yes	LT Debt/Eq	0.13	Earnings	Aug 03 AMC	Payout	-	Avg Volume	266.11K	Price	7.46
Recom	1.64	SMA20	3.10%	SMA50	-10.34%	SMA200	-46.78%	Volume	68,332	Change	2.47%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-09-22	Resumed	Jefferies	Buy	$61 → $55
Oct-17-22	Initiated	JP Morgan	Neutral	$27
Aug-29-22	Initiated	BofA Securities	Buy	$34
Dec-13-21	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$51
Nov-05-21	Upgrade	Wedbush	Neutral → Outperform
Aug-26-21	Initiated	Morgan Stanley	Overweight	$100
Jan-29-21	Initiated	RBC Capital Mkts	Outperform	$121
Jan-19-21	Reiterated	H.C. Wainwright	Buy	$88 → $114
Dec-22-20	Downgrade	Wedbush	Outperform → Neutral
Jul-17-20	Initiated	Robert W. Baird	Outperform	$90
Jul-01-20	Initiated	H.C. Wainwright	Buy	$88
May-28-20	Initiated	SunTrust	Buy	$86
Apr-22-20	Initiated	Wedbush	Outperform	$73
Oct-14-19	Initiated	Stifel	Buy	$32
Oct-14-19	Initiated	Piper Jaffray	Overweight	$26
Oct-14-19	Initiated	Jefferies	Buy	$25
Oct-14-19	Initiated	Guggenheim	Buy	$30

Show Previous Ratings

Sep-20-23 04:36AM	Orchard Therapeutics PLC Sponsored ADR (ORTX) Soars 12.9%: Is Further Upside Left in the Stock? (Zacks)
Sep-06-23 07:00AM	IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-10-23 08:59PM	Down More Than 50%: These 2 Strong Buy Stocks Are Too Cheap to Ignore (TipRanks)
Aug-03-23 05:25PM	IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:10PM	IGM Biosciences Announces Second Quarter 2023 Financial Results (GlobeNewswire)
06:46AM	Loading…
Jul-05-23 06:46AM	Daily Vickers Top Buyers & Sellers for 07/05/2023 (Argus Research)
Jul-03-23 04:01PM	IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Jun-30-23 09:48AM	While hedge funds own 27% of IGM Biosciences, Inc. (NASDAQ:IGMS), individual investors are its largest shareholders with 28% ownership (Simply Wall St.)
Jun-22-23 08:14PM	Strength Seen in IGM Biosciences, Inc. (IGMS): Can Its 7.6% Jump Turn into More Strength? (Zacks) +7.62%
07:58AM	IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement (GlobeNewswire)
Jun-21-23 05:17PM	IGM Announces Proposed Public Offering and Concurrent Private Placement (GlobeNewswire) -5.50%
Jun-02-23 05:30PM	IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development (GlobeNewswire) +5.92%
Jun-01-23 07:00AM	IGM Biosciences to Present at the Jefferies Healthcare Conference (GlobeNewswire) +6.56%
May-31-23 07:00AM	IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis (GlobeNewswire)
May-30-23 07:00AM	IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update (GlobeNewswire)
11:58AM	Loading…
May-25-23 11:58AM	Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation (Simply Wall St.)
May-12-23 10:15AM	IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
09:05AM	IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-02-23 07:00AM	IGM Biosciences to Present at Two Upcoming Investor Conferences (GlobeNewswire)
Apr-28-23 11:50AM	Bullish IGM Biosciences, Inc. (NASDAQ:IGMS) insiders filled their treasuries with US$1.6m worth of stock over last year (Simply Wall St.)
Apr-19-23 07:00AM	IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days (GlobeNewswire)
Apr-13-23 04:05PM	IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023 (GlobeNewswire) +14.63%
Apr-06-23 12:23PM	IGM Biosciences, Inc. (NASDAQ:IGMS) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-01-23 09:17AM	Further weakness as IGM Biosciences (NASDAQ:IGMS) drops 11% this week, taking three-year losses to 77% (Simply Wall St.)
Mar-30-23 06:05PM	IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-27-23 07:00AM	IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023 (GlobeNewswire) +6.70%
Feb-02-23 07:00AM	IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference (GlobeNewswire) +9.67%
Jan-17-23 07:00AM	IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors (GlobeNewswire)
Jan-09-23 07:00AM	IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development (GlobeNewswire) +8.66%
07:00AM	Loading…
Jan-03-23 07:00AM	IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-11-22 10:00AM	IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting (GlobeNewswire)
Dec-01-22 07:00AM	IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference (GlobeNewswire)
Nov-16-22 06:37AM	The Independent Director of IGM Biosciences, Inc. (NASDAQ:IGMS), M. Behrens, Just Bought 27% More Shares (Simply Wall St.)
Nov-08-22 07:00AM	IGM Biosciences to Present at Three Upcoming Investor Conferences (GlobeNewswire)
Nov-03-22 10:25AM	IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -8.46%
09:05AM	IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-02-22 04:05PM	IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkins Lymphoma (GlobeNewswire)
Oct-27-22 02:06PM	Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation (Simply Wall St.)
Sep-06-22 07:00AM	IGM Biosciences to Present at Three Upcoming Investor Conferences (GlobeNewswire) -5.77%
Aug-08-22 06:45PM	IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +9.77%
04:10PM	IGM Biosciences Announces Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-04-22 02:04PM	IGM Biosciences, Inc. (NASDAQ:IGMS) insiders placed bullish bets worth US$2.3m in the last 12 months (Simply Wall St.)
Jun-01-22 07:00AM	IGM Biosciences to Present at the 2022 Jefferies Healthcare Conference (GlobeNewswire)
May-20-22 12:07PM	We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate (Simply Wall St.)
May-10-22 07:00AM	IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference (GlobeNewswire) +5.34%
May-09-22 04:16PM	IGM Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -12.23%
May-06-22 07:00AM	IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi (GlobeNewswire)
Apr-09-22 09:35AM	Nielsen, IGM Biosciences, and, Yes, Twitter, See Action From Activist Investors (Barrons.com)
Apr-06-22 04:39PM	IGM Announces Closing of $230.0 Million Public Offering (GlobeNewswire) +8.33%
Apr-05-22 04:56PM	What Kind Of Investors Own Most Of IGM Biosciences, Inc. (NASDAQ:IGMS)? (Simply Wall St.)
Mar-30-22 03:06PM	Why Did Truist Lower IGM Biosciences' Price Target? (Benzinga) -12.34%
02:14PM	Is IGM Biosciences Stock a Buy Following Sanofi Deal Surge? RBC Weighs In (TipRanks)
01:29PM	Biotech Stock Roundup: AXSM to Acquire JAZZ's Drug, IGMS Up on SNY Deal & More (Zacks)
11:57AM	IGM (IGMS) Skyrockets on Collaboration Deal With Sanofi (Zacks)
12:56AM	IGM Announces Pricing of $200.0 Million Public Offering (GlobeNewswire)
Mar-29-22 11:41AM	Why IGM Biosciences Stock Rocketed Higher Today (Motley Fool) +96.73%
09:00AM	These 2 Stocks Are Up 20%-Plus in Tuesday's Premarket (Motley Fool)
08:54AM	IGM Biosciences Shares Rise on Collaboration Agreement with Sanofi (Investing.com)
07:59AM	Midday Stock Movers: Nielsen, Robinhood, IGM Biosciences Rise (Investing.com)
07:41AM	IGM Announces Proposed Public Offering (GlobeNewswire)
06:01AM	IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
02:00AM	IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi (GlobeNewswire)
Feb-09-22 03:34PM	Why Did IGM Biosciences Shares Advance Today? (Benzinga) +9.35%
07:00AM	IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment and Prevention of COVID-19 (GlobeNewswire)
Feb-03-22 04:05PM	IGM Biosciences to Present at the Guggenheim 2022 Oncology Conference (GlobeNewswire)
Jan-10-22 10:00AM	Here's Why IGM Biosciences, Inc. (IGMS) is Poised for a Turnaround After Losing 50.6% in 4 Weeks (Zacks)
Jan-05-22 07:00AM	IGM Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.66%
Dec-13-21 09:43AM	IGM Biosciences' B Cell Malignancies Trial Data Fails To Lift The Stock (Benzinga) -41.31%
07:08AM	IGM Biosciences Stock Plunges After Downgrade on Trial Data (Investing.com)
Dec-11-21 01:31PM	IGM Biosciences Presents Clinical Data from IGM-2323 in Patients with Advanced B Cell Malignancies at 2021 American Society of Hematology Annual Meeting (GlobeNewswire)
Dec-09-21 07:36AM	Recent gains in IGM Biosciences, Inc. (NASDAQ:IGMS) help add back some value on insider purchases worth US$4.0m, still down US$1.7m (Simply Wall St.)
Dec-08-21 07:00AM	IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria (GlobeNewswire)
Dec-06-21 04:05PM	IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 63rd Annual ASH Meeting (GlobeNewswire)
Nov-10-21 04:05PM	IGM Biosciences to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
11:15AM	Were Hedge Funds Right About Dumping IGM Biosciences, Inc. (IGMS)? (Insider Monkey)
Nov-08-21 07:00AM	IGM Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference (GlobeNewswire)
Nov-04-21 11:25AM	Notable Igm Biosciences Insider Trades $130K In Company Stock (Benzinga)
09:21AM	IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-11-21 04:05PM	IGM Biosciences Announces Leadership Appointments and Formation of IGM Infectious Diseases and IGM Autoimmunity and Inflammation Business Units (GlobeNewswire)
Oct-06-21 11:44AM	Notable Igm Biosciences Insider Trades $165K In Company Stock (Benzinga) -9.29%
Sep-23-21 04:05PM	IGM Biosciences to Present at the 2021 Cantor Virtual Global Healthcare Conference (GlobeNewswire)
Sep-10-21 09:01AM	IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Sep-07-21 07:00AM	IGM Biosciences to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Aug-09-21 04:06PM	IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire) +5.84%
Jul-29-21 05:31PM	IGM Biosciences Announces the Appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., as Chief Medical Officer (GlobeNewswire)
Jul-26-21 08:17PM	Were Hedge Funds Right About Piling Into IGM Biosciences, Inc. (IGMS)? (Insider Monkey)
Jun-12-21 05:05AM	Have Insiders Been Buying IGM Biosciences, Inc. (NASDAQ:IGMS) Shares? (Simply Wall St.)
Jun-03-21 07:01AM	IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication of Preclinical Data in Nature Demonstrating Engineered IgM Antibody Antiviral Activity for the Treatment and Prevention of COVID-19 (GlobeNewswire) +8.74%
May-26-21 07:00AM	IGM Biosciences to Present at the Jefferies Virtual Healthcare Conference (GlobeNewswire) +6.36%
May-12-21 07:00AM	IGM Biosciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-03-21 08:02AM	MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders (GlobeNewswire)
Apr-27-21 07:00AM	IGM Biosciences to Present at the Truist Securities Life Sciences Summit (GlobeNewswire)
Apr-12-21 07:00AM	IGM Biosciences Appoints George Gauthier as Chief Commercial Officer (GlobeNewswire) -9.33%
Mar-30-21 04:17PM	IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update (GlobeNewswire)
02:30PM	IGM Biosciences Inc to Host Earnings Call (ACCESSWIRE)
Mar-24-21 07:00AM	IGM Biosciences to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021 (GlobeNewswire) -11.57%
Mar-15-21 07:00AM	IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer (GlobeNewswire)
Mar-14-21 05:52AM	IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Mar-08-21 09:51AM	5 Value Stocks In The Healthcare Sector (Benzinga) -8.57%

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firm's product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies, IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies, and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gauthier George	Chief Commercial Officer	Jul 03	Sale	9.42	936	8,818	40,017	Jul 05 09:08 PM
Topsoe Jakob Haldor	Director	Jun 30	Buy	9.25	3,500	32,375	81,644	Jul 03 06:46 PM
Topsoe Christina Teng	Director	Jun 30	Buy	9.32	3,000	27,957	9,800	Jul 05 09:07 PM
Redmile Group, LLC	Director	Jun 29	Buy	9.42	80,423	757,585	2,974,186	Jul 03 09:45 PM
Topsoe Jakob Haldor	Director	Jun 29	Buy	9.10	3,500	31,846	78,144	Jul 03 06:46 PM
Redmile Group, LLC	Director	Jun 29	Sale	9.42	80,423	757,585	2,893,763	Jul 03 09:45 PM
BEHRENS M KATHLEEN	Director	Jun 26	Buy	8.00	112,500	900,000	330,700	Jun 28 07:34 PM
Gauthier George	Chief Commercial Officer	May 23	Sale	12.31	1,259	15,497	40,953	May 25 07:20 PM
Decker Lisa Lynn	Chief Business Officer	May 23	Sale	12.31	1,259	15,497	41,181	May 25 07:20 PM
Tahir Misbah	Chief Financial Officer	May 23	Sale	12.31	1,259	15,497	50,711	May 25 07:23 PM
Takimoto Chris H	Chief Medical Officer	May 23	Sale	12.31	1,259	15,497	54,742	May 25 07:24 PM
Schwarzer Fred	CEO and President	May 23	Sale	12.31	1,259	15,497	121,761	May 25 07:22 PM
Keyt Bruce	Chief Scientific Officer	May 23	Sale	12.31	982	12,088	138,058	May 25 07:21 PM
Gauthier George	Chief Commercial Officer	Apr 05	Sale	12.60	935	11,781	33,878	Apr 06 09:39 PM
Takimoto Chris H	Chief Medical Officer	Mar 14	Sale	18.73	1,768	33,118	28,789	Mar 16 06:31 PM
Tahir Misbah	Chief Financial Officer	Mar 14	Sale	18.73	1,768	33,118	25,322	Mar 16 06:30 PM
Keyt Bruce	Chief Scientific Officer	Mar 14	Sale	18.73	1,293	24,220	90,704	Mar 16 06:30 PM
Gauthier George	Chief Commercial Officer	Mar 14	Sale	18.73	1,061	19,875	18,563	Mar 16 06:28 PM
Decker Lisa Lynn	Chief Business Officer	Mar 14	Sale	18.73	1,061	19,875	16,732	Mar 16 06:27 PM
Keyt Bruce	Chief Scientific Officer	Jan 05	Option Exercise	0.93	33,756	31,393	91,997	Jan 09 06:16 PM
Tahir Misbah	Chief Financial Officer	Dec 19	Sale	20.00	3,801	76,020	27,090	Dec 20 08:09 PM
Schwarzer Fred	CEO and President	Dec 16	Sale	18.98	12,369	234,805	20,360	Dec 20 08:08 PM
Takimoto Chris H	Chief Medical Officer	Dec 16	Sale	18.98	5,430	103,080	30,557	Dec 20 08:12 PM
Keyt Bruce	Chief Scientific Officer	Dec 16	Sale	18.98	5,371	101,960	58,241	Dec 20 08:07 PM
Gauthier George	Chief Commercial Officer	Dec 16	Sale	18.98	4,354	82,654	19,624	Dec 20 08:06 PM
Decker Lisa Lynn	Chief Business Officer	Dec 16	Sale	18.98	2,484	47,154	17,793	Dec 20 08:05 PM
Tahir Misbah	Chief Financial Officer	Dec 16	Sale	18.98	2,283	43,339	30,891	Dec 20 08:09 PM
Keyt Bruce	Chief Scientific Officer	Dec 14	Option Exercise	0.93	25,000	23,250	63,612	Dec 16 07:40 PM
Gauthier George	Chief Commercial Officer	Nov 23	Sale	21.57	1,258	27,136	23,978	Nov 28 08:28 PM
Decker Lisa Lynn	Chief Business Officer	Nov 23	Sale	21.57	1,258	27,136	20,277	Nov 28 08:27 PM
Schwarzer Fred	CEO and President	Nov 23	Sale	21.57	1,258	27,136	32,729	Nov 28 08:30 PM
Takimoto Chris H	Chief Medical Officer	Nov 23	Sale	21.57	877	18,918	35,987	Nov 28 08:31 PM
Tahir Misbah	Chief Financial Officer	Nov 23	Sale	21.57	877	18,918	33,174	Nov 28 08:31 PM
Keyt Bruce	Chief Scientific Officer	Nov 23	Sale	21.57	877	18,918	38,612	Nov 28 08:29 PM
BEHRENS M KATHLEEN	Director	Nov 08	Buy	17.14	60,000	1,028,550	218,200	Nov 10 05:10 PM
Keyt Bruce	Chief Scientific Officer	Oct 04	Option Exercise	0.93	25,000	23,250	64,489	Oct 06 07:16 PM
Keyt Bruce	Chief Scientific Officer	Oct 04	Sale	22.84	25,000	570,980	39,489	Oct 06 07:16 PM
LOBERG MICHAEL D	Director	Sep 29	Buy	19.62	5,821	114,213	35,305	Oct 03 08:11 PM
LOBERG MICHAEL D	Director	Sep 28	Buy	20.97	6,172	129,403	29,484	Sep 29 06:05 PM
LOBERG MICHAEL D	Director	Sep 27	Buy	19.99	507	10,137	23,312	Sep 29 06:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IGMS | IGM Biosciences Inc

Upgrade your FINVIZ experience